跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXALITIN - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
OXALITIN
Approved
STANDARD
OXALITIN
BORYUNG PHARMACEUTICAL CO., LTD
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
670afcc38210b06f
Company
BORYUNG PHARMACEUTICAL CO., LTD
Type
Standard
Approval Details
Approval Id
670afcc38210b06f
Drug Approval Philippines Name
OXALITIN
Product Name
OXALITIN
Registration Number
DR-XY46143
Brand Name
OXALITIN
Generic Name
OXALIPLATIN
Dosage Form
Solution for Injection for IV use
Dosage Strength
5 mg/mL
Manufacturer
BORYUNG PHARMACEUTICAL CO., LTD
Importer
Endure Medical Inc.
Distributor
Endure Medical Inc.
Company Detail Path
/organization/boryung-pharmaceutical-co-ltd
Issuance Date
05 August 2022
Expiry Date
02 November 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
670afcc38210b06f
Type
Standard
Back to Philippines FDA Approvals